Evidence Type	Pubmed ID	Sentence
Diagnostic	29214759	JAK2 V617F is the most common mutation;in myeloproliferative neoplasms (MPNs);and is a major diagnostic criterion.
Predictive	28456787	In non-small cell lung cancer (NSCLC);driver mutations of EGFR are positive;predictive biomarkers for efficacy of;erlotinib and gefitinib .
Predisposing	28222693	Our study suggests that one BRCA1;variant may be associated with;increased risk of breast cancer.
Prognostic	28469333	Overexpression of Her2 in breast cancer;is a key feature of pathobiology of the;disease and is associated with poor;prognosis.
